ESC 365 - Vulnerability of carotid atherosclerosis: relationship with plaque location, plaque eccentricity and vessel remodeling patterns. Insight from the the MAGNETIC observational study

ESC Premium Access

Vulnerability of carotid atherosclerosis: relationship with plaque location, plaque eccentricity and vessel remodeling patterns. Insight from the the MAGNETIC observational study

Session: New data in carotid disease: From understanding the pathology to management

Topic: Pathophysiology and Mechanisms

Speaker: Doctor O. Catalano (Pavia, IT)

Event: ESC CONGRESS 2019

Congress Presentation

About the speaker

Doctor Oronzo Catalano

Istituti Clinici Scientifici Maugeri IRCCS, Pavia (Italy)

0 follower

9 more presentations in this session

Plaque burden, but not the severity of carotid stenosis, predicts adverse cardiovascular events in patients at high and very high cardiovascular risk

Speaker: Mr V. Genkel (Chelyabinsk, RU)

Wall shear stress measurement by ultrafast vector flow imaging for atherosclerotic carotid stenosis

Speaker: Mr G. Goudot (Paris, FR)

Gender differences in the prevalence of a normal IMT with increasing severity of carotid disease.

Speaker: Doctor M. Matangi (Kingston, CA)

Endotrophin, a fragment of collagen type VI, is correlated to IMT and associated with cardiovascular events in patients with atherosclerosis and diabetes: the IMI-SUMMIT cohort

Speaker: Doctor S. Holm Nielsen (Kongens Lyngby, DK)

Exploration of biomarkers for subclinical atherosclerosis in an African population using a proteomics chip targeted at inflammation and cardiovascular disease

Speaker: Doctor A. Jujic (Malmo, SE)

Access the full session

New data in carotid disease: From understanding the pathology to management

Speakers: Doctor O. Catalano, Mr V. Genkel, Mr G. Goudot, Doctor M. Matangi, Doctor S. Holm Nielsen...

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

ESC Premium Access

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

27 August 2021

ESC Premium Access

EMPEROR-Preserved - Discussant review.

27 August 2021

ESC Premium Access

EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

27 August 2021

ESC 365 is supported by